Pere Godoy Garcia

Vilela Á; Bach P; Godoy P

Cumplimiento del estudio de contactos de personas diagnosticadas de VIH/ITS en las comarcas de Lleida.

Revista Espanola de Salud Publica 93 -. 02/12/2019.

Sanchez, E; Lecube, A; Betriu À; Hernandez, C; Lopez-Cano, C; Gutierrez-Carrasquilla, L; Kerkeni, M; Yeramian, A; Purroy, F; Pamplona, R; Farràs C; Fernandez, E; Barbe, F; Simo, R; ILERVAS project; Hernández M; Rius F; Polanco D; de la Torre MS; Torres G; Godoy P; Portero-Otin M; Jové M; Colàs-Compàs L; Benabdelhak I; Miquel E; Ortega M; Valdivielso JM; Bermúdez M; Martínez-Alonso M

Subcutaneous advanced glycation end-products and lung function according to glucose abnormalities: The MR-1 ILERVAS Project

Diabetes & metabolism 45 595-598. 01/12/2019.

[doi:10.1016/j.diabet.2018.04.002]

Montserrat-Capdevila, J; Godoy, P; Marsal, JR; Ortega, M; Barbe, F; Castan, MT; Seminario, MA; Pujol, J; Alseda, M

Prevalence and characteristics of chronic obstructive pulmonary disease in non-smokers

ATENCION PRIMARIA 51 602-609. 01/12/2019.

[doi:10.1016/j.aprim.2017.10.012]

Montserrat-Capdevila J; Godoy P; Marsal JR; Ortega M; Barbé F; Castañ MT; Seminario MA; Pujol J; Alsedà M

Prevalencia y características de la enfermedad pulmonar obstructiva crónica en no fumadores.

ATENCION PRIMARIA 51 589-590. 01/11/2019.

[doi:10.1016/j.aprim.2019.04.002]

Godoy, P; Alseda, M

Surveillance of tuberculosis contacts: How can the strategy be improved?

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA 37 493-495. 01/10/2019.

[doi:10.1016/j.eimc.2019.04.008]

Plans-Rubio, P; Navas, E; Godoy, P; Carmona, G; Dominguez, A; Jane, M; Muñoz-Almagro C; Brotons, P

Reduction of Direct Health Costs Associated with Pertussis Vaccination with Acellular Vaccines in Children Aged 0-9 Years with Pertussis in Catalonia (Spain)

PHARMACOECONOMICS-OPEN 3 55-69. 01/03/2019.

[doi:10.1007/s41669-018-0081-4]

Borràs E; Urbiztondo L; Carmona G; Jané M; Barrabeig I; Rosa Sala M; Jorgina Balañà JP; Company M; Parrón I; Godoy P; Rius C; Soldevila N; Cabezas C; Domínguez À

Effectiveness and impact of the hepatitis B vaccination program in preadolescents in Catalonia 21 years after its introduction

Vaccine 37 1137-1141. 21/02/2019.

[doi:10.1016/j.vaccine.2019.01.024]

Martínez A; Soldevila N; Romero-Tamarit A; Torner N; Godoy P; Rius C; Jané M; Domínguez À

Risk factors associated with severe outcomes in adult hospitalized patients according to influenza type and subtype

PLOS ONE 14 -. 11/01/2019.

[doi:10.1371/journal.pone.0210353]

Valero-Rello, A; Henares, D; Acosta, L; Jane, M; Jordan, I; Godoy, P; Muñoz-Almagro C

Validation and Implementation of a Diagnostic Algorithm for DNA Detection of Bordetella pertussis, B. parapertussis, and B-holmesii in a Pediatric Referral Hospital in Barcelona, Spain

JOURNAL OF CLINICAL MICROBIOLOGY 57 -. 01/01/2019.

[doi:10.1128/JCM.01231-18]

Dominguez, A; Astray, J; Castilla, J; Godoy, P; Tuells, J; Barrabeig, I

False beliefs about vaccines

ATENCION PRIMARIA 51 40-46. 01/01/2019.

[doi:10.1016/j.aprim.2018.05.004]

Montserrat-Capdevila, J; Seminario, MA; Godoy, P; Marsal, JR; Ortega, M; Pujol, J; Castan, MT; Alseda, M; Betriu À; Lecube, A; Portero, M; Purroy, F; Valdivielso, JM; Barbe, F

Prevalence of chronic obstructive pulmonary disease (COPD) not diagnosed in a population with cardiovascular risk factors

MEDICINA CLINICA 151 383-389. 21/11/2018.

[doi:10.1016/j.medcli.2017.12.018]

Godoy P; Romero A; Soldevila N; Torner N; Jané M; Martínez A; Caylà JA; Rius C; Domínguez A

Influenza vaccine effectiveness in reducing severe outcomes over six influenza seasons, a case-case analysis, Spain, 2010/11 to 2015/16

Eurosurveillance 23 13-21. 25/10/2018.

[doi:10.2807/1560-7917.ES.2018.23.43.1700732]